AnaptysBio Inc (ANAB)
14.50
-0.50
(-3.33%)
USD |
NASDAQ |
Dec 20, 16:00
14.54
+0.04
(+0.31%)
After-Hours: 20:00
AnaptysBio Profit Margin (Quarterly): -109.4% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| SIGA Technologies Inc | 13.43% |
| Candel Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -236.3% |
| Return on Assets | -36.55% |
| Return on Invested Capital | -236.3% |
| Operating Margin (Quarterly) | -75.81% |
| Return on Net Operating Assets | -652.6% |